Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ligand Pharmaceuticals (LGND) Tax Rate (2016 - 2025)

Historic Tax Rate for Ligand Pharmaceuticals (LGND) over the last 16 years, with Q3 2025 value amounting to 16.91%.

  • Ligand Pharmaceuticals' Tax Rate rose 300500.0% to 16.91% in Q3 2025 from the same period last year, while for Sep 2025 it was 22.86%, marking a year-over-year decrease of 2100.0%. This contributed to the annual value of 260.13% for FY2024, which is 2446700.0% up from last year.
  • Ligand Pharmaceuticals' Tax Rate amounted to 16.91% in Q3 2025, which was up 300500.0% from 56.81% recorded in Q2 2025.
  • In the past 5 years, Ligand Pharmaceuticals' Tax Rate ranged from a high of 160.21% in Q4 2022 and a low of 214.12% during Q1 2021
  • Over the past 5 years, Ligand Pharmaceuticals' median Tax Rate value was 16.91% (recorded in 2025), while the average stood at 6.39%.
  • As far as peak fluctuations go, Ligand Pharmaceuticals' Tax Rate crashed by -2347800bps in 2021, and later soared by 1727300bps in 2022.
  • Over the past 5 years, Ligand Pharmaceuticals' Tax Rate (Quarter) stood at 22.83% in 2021, then surged by 602bps to 160.21% in 2022, then crashed by -104bps to 6.38% in 2023, then soared by 424bps to 20.69% in 2024, then dropped by -18bps to 16.91% in 2025.
  • Its Tax Rate was 16.91% in Q3 2025, compared to 56.81% in Q2 2025 and 15.4% in Q1 2025.